When IL-6 levels are elevated, as seen in chronic inflammation or autoimmune diseases, there is increased activation of these promoter elements, leading to higher synthesis of apolipoprotein(a) and consequently increased Lp(a) concentrations in the blood [92, 93] (Fig. 2). Here, LPA is linked to autoimmune disease.